Literature DB >> 10525973

Long-term follow-up of isolated optic neuritis: the risk of developing multiple sclerosis, its outcome, and the prognostic role of paraclinical tests.

A Ghezzi1, V Martinelli, V Torri, M Zaffaroni, M Rodegher, G Comi, A Zibetti, N Canal.   

Abstract

We evaluated the risk of developing clinically definite multiple sclerosis (CDMS) after an acute attack of isolated optic neuritis (ON) in 112 patients, in relation to demographic and paraclinical findings. Patients were examined by brain MRI, CSF analysis, and multiple evoked potentials (EPs); 10 were lost to follow-up, and the other 102 were enrolled in a prospective study (follow-up duration 6. 3 +/- 2.2 years). Of these, 37 (36.3%) developed CDMS after a mean interval of 2.3 +/- 1.6 years. The risk of developing CDMS was 13% after 2 years, 30% after 4, 37% after 6, and 42% after 8 and 10 years. Gender, age, and season of ON onset did not affect the risk. MS occurred in 37 of 71 patients (52.1%) with one MRI lesion or more; no patient with a normal MRI developed the disease. MS developed more frequently in patients with intrathecal IgG synthesis than in those without (43% vs. 28%), but the difference was not statistically significant. Multiple EPs showed a slight predictive value only including somatosensory EPs of the lower limb. Multiple sclerosis was mild in most cases (EDSS 2.2 +/- 1.9). The EDSS was less than 4 in 32 cases (86%), between 4 and 6 in 2 (5%), higher than 6.5 in 3 (8%).

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10525973     DOI: 10.1007/s004150050453

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  25 in total

1.  Correlation between full-field and multifocal VEPs in optic neuritis.

Authors:  Alexander Klistorner; Clare Fraser; Raymond Garrick; Stuart Graham; Hemamalini Arvind
Journal:  Doc Ophthalmol       Date:  2007-08-07       Impact factor: 2.379

Review 2.  Neurophysiological markers.

Authors:  Letizia Leocani; Giancarlo Comi
Journal:  Neurol Sci       Date:  2008-09       Impact factor: 3.307

3.  Management of optic neuritis in Canada: survey of ophthalmologists and neurologists.

Authors:  Edward J Atkins; Carolyn D Drews-Botsch; Nancy J Newman; Olivier Calvetti; Seegar Swanson; Valérie Biousse
Journal:  Can J Neurol Sci       Date:  2008-05       Impact factor: 2.104

4.  Predicting the outcome of optic neuritis: evaluation of risk factors after 30 years of follow-up.

Authors:  Petra Nilsson; Elna-Marie Larsson; Pia Maly-Sundgren; Roland Perfekt; Magnhild Sandberg-Wollheim
Journal:  J Neurol       Date:  2005-03-22       Impact factor: 4.849

Review 5.  The retina as a window to the brain-from eye research to CNS disorders.

Authors:  Anat London; Inbal Benhar; Michal Schwartz
Journal:  Nat Rev Neurol       Date:  2012-11-20       Impact factor: 42.937

Review 6.  Multiple sclerosis in childhood and adolescence: clinical features and management.

Authors:  O Pinhas-Hamiel; I Sarova-Pinhas; A Achiron
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

7.  Myelin oligodendrocyte glycoprotein-specific T and B cells cooperate to induce a Devic-like disease in mice.

Authors:  Estelle Bettelli; Dominique Baeten; Anneli Jäger; Raymond A Sobel; Vijay K Kuchroo
Journal:  J Clin Invest       Date:  2006-09       Impact factor: 14.808

8.  Optic neuritis in different strains of mice by a recombinant HSV-1 expressing murine interleukin-2.

Authors:  Mandana Zandian; Raelene Belisle; Kevin R Mott; Steven Nusinowitz; Florence M Hofman; Homayon Ghiasi
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-02-21       Impact factor: 4.799

9.  Multiple sclerosis risk after optic neuritis: final optic neuritis treatment trial follow-up.

Authors: 
Journal:  Arch Neurol       Date:  2008-06

10.  Updates on clinically isolated syndrome and diagnostic criteria for multiple sclerosis.

Authors:  Jacqueline F Marcus; Emmanuelle L Waubant
Journal:  Neurohospitalist       Date:  2013-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.